Tenax Therapeutics Ownership | Who Owns Tenax Therapeutics?

Tenax Therapeutics Ownership Summary

Tenax Therapeutics is owned by 4.01% institutional investors, 0.12% insiders, and 95.87% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 7.53% of TENX shares. Fidelity Select Biotechnology is the top mutual fund, with 3.65% of its assets in Tenax Therapeutics shares.

TENX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenax Therapeutics	4.01%	0.12%	95.87%
Sector	Healthcare Stocks	50.53%	12.40%	37.07%
Industry	Biotech Stocks	48.96%	12.12%	38.92%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Price t rowe associates inc /md/	2.95M	7.53%	$47.19M
Janus henderson group	1.82M	4.63%	$29.07M
Perceptive advisors	1.45M	3.69%	$23.15M
Ikarian capital	1.02M	2.59%	$16.27M
Stonepine capital management	975.20K	2.49%	$15.59M
Logos global management lp	625.00K	1.59%	$9.99M
Morgan stanley	596.56K	1.52%	$9.54M
Velan capital investment management lp	583.33K	1.49%	$9.33M
Adage capital partners gp	540.13K	1.38%	$8.64M
Point72 asset management	533.97K	1.36%	$8.54M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Stonepine capital management	975.20K	6.24%	$15.59M
Velan capital investment management lp	583.33K	5.84%	$9.33M
Verdad advisers, lp	95.33K	1.72%	$1.52M
Ikarian capital	1.02M	1.32%	$16.27M
Avidity partners management lp	265.93K	0.79%	$3.49M
Stempoint capital lp	188.70K	0.59%	$3.02M
Logos global management lp	625.00K	0.50%	$9.99M
Perceptive advisors	1.45M	0.45%	$23.15M
Sphera funds management	136.01K	0.35%	$2.17M
Vivo capital	208.33K	0.28%	$3.33M

Top Buyers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	2.95M	0.01%	2.95M
Janus henderson group	1.82M	0.01%	1.65M
Perceptive advisors	1.45M	0.45%	1.01M
Stonepine capital management	975.20K	6.24%	963.32K
Logos global management lp	625.00K	0.50%	625.00K

Top Sellers

Holder	Shares	% Assets	Change
Vr adviser	-	-	-1.68M
Armistice capital	-	-	-478.83K
Great point partners	-	-	-327.31K
Ameriprise financial	-	-	-279.54K
Boone capital management	-	-	-200.00K

New Positions

Holder	Shares	% Assets	Change	Value
Price t rowe associates inc /md/	2.95M	0.01%	2.95M	$47.19M
Logos global management lp	625.00K	0.50%	625.00K	$9.99M
Td asset management	399.18K	0.01%	399.18K	$6.38M
Avidity partners management lp	265.93K	0.79%	265.93K	$3.49M
Stempoint capital lp	188.70K	0.59%	188.70K	$3.02M

Sold Out

Holder	Change
Mai capital management	-1.00
Wealthspire advisors	-1.00
Sbi securities	-2.00
Raymond james financial	-1.50K
Acadian asset management	-4.50K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	19	-60.42%	1,573,538	-77.36%	4	1.31%	13	-58.06%	1	-66.67%
Dec 31, 2025	19	-44.12%	2,128,813	-54.91%	5	3.76%	14	-30.00%	-	-100.00%
Sep 30, 2025	33	32.00%	4,720,737	111.51%	11	37.50%	20	150.00%	2	-50.00%
Jun 30, 2025	25	8.70%	2,231,961	11.24%	5	18.75%	8	-11.11%	4	33.33%
Mar 31, 2025	23	9.52%	2,006,422	47.29%	5	6.89%	9	-	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Select Biotechnology	969.20K	3.65%	969.20K
Vanguard Morn Total Stk Mkt Idx Investor	852.26K	3.21%	658.10K
Vanguard Total Stock Mkt Idx Inv	852.26K	3.21%	658.10K
FIAM Small Cap Core CIT Cl B	627.58K	2.37%	627.58K
Vanguard MStar Total Stk Mkt Idx Invest	852.26K	2.28%	-
iShares Russell 2000 ETF	640.34K	1.71%	-11.33K
T. Rowe Price Health Sciences	445.98K	1.68%	-1.94M
Strategic Advisers Fidelity US TtlStk	515.19K	1.38%	438.25K
Fidelity Advisor Biotechnology I	445.10K	1.19%	122.50K
TD Health Sciences - I	177.30K	1.03%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 20, 2026	ADAR1 Capital Management, LLC	-	Buy	$359.54K
Aug 24, 2026	ADAR1 Capital Management, LLC	-	Buy	$188.36K
Aug 21, 2026	ADAR1 Capital Management, LLC	-	Buy	$1.27M
Dec 09, 2025	Rich Stuart	Chief Medical Officer	Buy	$25.54K
Dec 08, 2025	Rich Stuart	Chief Medical Officer	Buy	$25.25K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	3	-
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	13	-
2025 Q3	-	-

TENX Ownership FAQ

Who Owns Tenax Therapeutics?

Tenax Therapeutics shareholders are primarily institutional investors at 4.01%, followed by 0.12% insiders and 95.87% retail investors. The average institutional ownership in Tenax Therapeutics's industry, Biotech Stocks , is 48.96%, which Tenax Therapeutics falls below.

Who owns the most shares of Tenax Therapeutics?

Tenax Therapeutics’s largest shareholders are Price t rowe associates inc /md/ (2.95M shares, 7.53%), Janus henderson group (1.82M shares, 4.63%), and Perceptive advisors (1.45M shares, 3.69%). Together, they hold 15.85% of Tenax Therapeutics’s total shares outstanding.

Does Blackrock own Tenax Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tenax Therapeutics.

Who is Tenax Therapeutics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Tenax Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.24% of its assets in 975.2K Tenax Therapeutics shares, valued at 15.59M$.

Who is the top mutual fund holder of Tenax Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of Tenax Therapeutics shares, with 3.65% of its total shares outstanding invested in 969.2K Tenax Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools